UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO Quant / Systematic

Name: UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO Q2 2017 13F Filing | 13F Explorer
Creator: UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
Published: 2017-08-03

Location: Austin, TX

CIK: 0001019231 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 3, 2017

Total Value: $33.64M (100.0% shares, 0.0% debt)

Holdings (24)

— WILLIAMS PARTNERS LP 20.6%

Value $6.928M Shares 172,732 Share Price $40.11 Est. Cost/Share $49.22 Unrealized @ Report Date —

VEA VANGUARD FTSE DEV MKTS 10.1%

Value $3.413M Shares 82,592 Share Price $41.32 Est. Cost/Share $38.68 Unrealized @ Report Date —

VOO VANGUARD 500 INDEX FUND 9.0%

Value $3.041M Shares 13,695 Share Price $222.05 Est. Cost/Share $182.90 Unrealized @ Report Date —

VOE VANGUARD MID-CAP VALUE ETF 8.9%

Value $3.001M Shares 29,172 Share Price $102.87 Est. Cost/Share $85.98 Unrealized @ Report Date —

VWO VANGUARD MSCI EMERGING MKTS 7.8%

Value $2.627M Shares 64,329 Share Price $40.84 Est. Cost/Share $38.55 Unrealized @ Report Date —

TXN TEXAS INSTRUMENTS INC 7.3%

Value $2.462M Shares 32,000 Share Price $76.94 * Est. Cost/Share $25.31 Unrealized @ Report Date +149.5%

— AEGLEA BIOTHERAPEUTICS INC 6.0%

Value $2.021M Shares 524,929 Share Price $3.85 Est. Cost/Share $6.41 Unrealized @ Report Date —

— BIO-PATH HOLDINGS INC 4.3%

Value $1.456M Shares 3,830,882 Share Price $0.38 Est. Cost/Share $2.63 Unrealized @ Report Date —

— MIRAGEN THERAPEUTICS INC 4.1%

Value $1.364M Shares 105,465 Share Price $12.93 Est. Cost/Share $12.44 Unrealized @ Report Date —

— APOLLO ENDOSURGERY INC 3.6%

Value $1.217M Shares 154,301 Share Price $7.89 Est. Cost/Share $12.52 Unrealized @ Report Date —

XOM EXXON MOBIL CORPORATION 3.4%

Value $1.13M Shares 14,000 Share Price $80.71 * Est. Cost/Share $55.47 Unrealized @ Report Date 0.0%

— GENERAL MOLY INC 3.2%

Value $1.08M Shares 2,922,831 Share Price $0.37 Est. Cost/Share $1.15 Unrealized @ Report Date —

VDE VANGUARD ENERGY ETF 2.7%

Value $908K Shares 10,260 Share Price $88.50 Est. Cost/Share $113.79 Unrealized @ Report Date —

VNQ VANGUARD REIT ETF 2.3%

Value $765K Shares 9,189 Share Price $83.25 Est. Cost/Share $72.18 Unrealized @ Report Date —

LXRX LEXICON PHARMACEUTICALS INC 1.7%

Value $587K Shares 35,714 Share Price $16.44 * Est. Cost/Share $7.34 Unrealized @ Report Date +110.8%

— GLOBAL BLOOD THERAPEUTICS INC 1.4%

Value $487K Shares 17,800 Share Price $27.36 Est. Cost/Share $27.36 Unrealized @ Report Date —

— JOUNCE THERAPEUTICS INC 1.3%

Value $428K Shares 30,488 Share Price $14.04 Est. Cost/Share $21.98 Unrealized @ Report Date —

— PLX PHARMA INC 1.1%

Value $385K Shares 62,673 Share Price $6.14 Est. Cost/Share $6.14 Unrealized @ Report Date —

PK PARK HOTELS & RESORTS INC 0.8%

Value $258K Shares 9,587 Share Price $26.91 Est. Cost/Share $25.66 Unrealized @ Report Date —

— MONSANTO CO 0.2%

Value $61,000 Shares 515 Share Price $118.45 Est. Cost/Share $118.45 Unrealized @ Report Date —

— DISCOVERY COMMUNICATIONS INC., SERIES C 0.0%

Value $7,000 Shares 290 Share Price $24.14 Est. Cost/Share $24.14 Unrealized @ Report Date —

JNJ JOHNSON & JOHNSON 0.0%

Value $6,000 Shares 47 Share Price $127.66 * Est. Cost/Share $100.38 Unrealized @ Report Date 0.0%

POR PORTLAND GENERAL ELECTRIC CO 0.0%

Value $5,000 Shares 118 Share Price $42.37 * Est. Cost/Share $20.00 Unrealized @ Report Date +66.0%

— DISCOVERY COMMUNICATIONS 0.0%

Value $3,000 Shares 115 Share Price $26.09 Est. Cost/Share $26.09 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	WILLIAMS PARTNERS LP	172,732	$6.928M	20.6%	$40.11	$49.22	—	LP - PUBLIC EQUITY	96949L105
VEA	VANGUARD FTSE DEV MKTS	82,592	$3.413M	10.1%	$41.32	$38.68	—	ETFS	921943858
VOO	VANGUARD 500 INDEX FUND	13,695	$3.041M	9.0%	$222.05	$182.90	—	ETFS	922908363
VOE	VANGUARD MID-CAP VALUE ETF	29,172	$3.001M	8.9%	$102.87	$85.98	—	ETFS	922908512
VWO	VANGUARD MSCI EMERGING MKTS	64,329	$2.627M	7.8%	$40.84	$38.55	—	ETFS	922042858
TXN	TEXAS INSTRUMENTS INC	32,000	$2.462M	7.3%	$76.94 *	$25.31	+149.5%	COM	882508104
—	AEGLEA BIOTHERAPEUTICS INC	524,929	$2.021M	6.0%	$3.85	$6.41	—	COM	00773J103
—	BIO-PATH HOLDINGS INC	3,830,882	$1.456M	4.3%	$0.38	$2.63	—	COM	09057N102
—	MIRAGEN THERAPEUTICS INC	105,465	$1.364M	4.1%	$12.93	$12.44	—	COM	60463E103
—	APOLLO ENDOSURGERY INC	154,301	$1.217M	3.6%	$7.89	$12.52	—	COM	03767D108
XOM	EXXON MOBIL CORPORATION	14,000	$1.13M	3.4%	$80.71 *	$55.47	0.0%	COM	30231G102
—	GENERAL MOLY INC	2,922,831	$1.08M	3.2%	$0.37	$1.15	—	COM	370373102
VDE	VANGUARD ENERGY ETF	10,260	$908K	2.7%	$88.50	$113.79	—	ETFS	92204A306
VNQ	VANGUARD REIT ETF	9,189	$765K	2.3%	$83.25	$72.18	—	ETFS	922908553
LXRX	LEXICON PHARMACEUTICALS INC	35,714	$587K	1.7%	$16.44 *	$7.34	+110.8%	COM	528872302
—	GLOBAL BLOOD THERAPEUTICS INC	17,800	$487K	1.4%	$27.36	$27.36	—	COM	37890U108
—	JOUNCE THERAPEUTICS INC	30,488	$428K	1.3%	$14.04	$21.98	—	COM	481116101
—	PLX PHARMA INC	62,673	$385K	1.1%	$6.14	$6.14	—	COM	72942A107
PK	PARK HOTELS & RESORTS INC	9,587	$258K	0.8%	$26.91	$25.66	—	FUNDS, REAL ESTATE INVESTMENT TRUSTS, DOMESTIC	700517105
—	MONSANTO CO	515	$61,000	0.2%	$118.45	$118.45	—	COM	61166W101
—	DISCOVERY COMMUNICATIONS INC., SERIES C	290	$7,000	0.0%	$24.14	$24.14	—	COM	25470F302
JNJ	JOHNSON & JOHNSON	47	$6,000	0.0%	$127.66 *	$100.38	0.0%	COM	478160104
POR	PORTLAND GENERAL ELECTRIC CO	118	$5,000	0.0%	$42.37 *	$20.00	+66.0%	COM	736508847
—	DISCOVERY COMMUNICATIONS	115	$3,000	0.0%	$26.09	$26.09	—	COM	25470F104